Quintana, Maria del Pilar
Ch’ng, Jun-Hong
Moll, Kirsten
Zandian, Arash https://orcid.org/0000-0003-1242-0873
Nilsson, Peter
Idris, Zulkarnain Md
Saiwaew, Somporn
Qundos, Ulrika
Wahlgren, Mats
Article History
Received: 5 December 2016
Accepted: 12 January 2018
First Online: 19 February 2018
Competing Interests
: M.W. is a co-founder and board member of Modus Therapeutics (known before as Dilaforette), a company developing drugs for the treatment of severe malaria. All the other authors declared that they have no competing interests.